altrexone as anti-craving medication in cannabis addicts
Phase 3
Withdrawn
- Conditions
- verslaving aan cannabiscannabis addiction
- Registration Number
- NL-OMON35633
- Lead Sponsor
- Centrum Maliebaan (Utrecht)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
male or female
between 18 - 60 years old
current primary diagnosis of cannabis abuse or dependence
able to provide written informed consent and to comply with all study procedures
Exclusion Criteria
currently dependent on opiates
currently majorly dependant on another substance other than cannabis or nicotine
severe medical illness
known allergy to Naltrexone
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method